Physician profile
Tuncay Taskesen
NPI 1245619741
$22,496.65
in general payments reported to CMS, 2019-2025
29 companies · $5,197 in 2025
The $5,197 reported for 2025 was more than what 99% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $780 · 2020: $463 · 2021: $780 · 2022: $2,441 · 2023: $4,207 · 2024: $8,628 · 2025: $5,197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Food and Beverage: $6,282 · Education: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,481.76 |
| Food and Beverage | $6,282.29 |
| Education | $268.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,274.50 | 2022-2025 | Corevalve Evolut R |
| Abbott Laboratories | $3,829.68 | 2019-2025 | Mitraclip, Supera, Amplatzer |
| Edwards Lifesciences Corporation | $3,643.74 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Penumbra, INC. | $3,186.38 | 2024-2025 | Indigo System, Ruby Coil |
| W. L. Gore & Associates, INC. | $1,789.08 | 2022-2025 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder |
| Boston Scientific Corporation | $585.96 | 2020-2025 | Watchman Flx, Wolverine Coronary Cutting Balloon |
| Astellas Pharma US INC | $465.23 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $316.20 | 2019-2025 | Lifevest |
| Medical Device Business Services, INC. | $303.75 | 2023 | Carto 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $244.70 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $234.71 | 2022-2023 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $229.93 | 2024-2025 | Camzyos |
| Abiomed | $185.55 | 2024 | Impella |
| Shockwave Medical, INC | $183.92 | 2022 | |
| Janssen Pharmaceuticals, INC | $181.84 | 2019-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $176.31 | 2025 | Optimizer |
| Inari Medical, INC. | $134.19 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $120.20 | 2022 | |
| Medtronic Vascular, INC. | $83.34 | 2019 | |
| Teleflex LLC | $75.17 | 2023-2024 | Manta, Supercross |
| Philips North America LLC | $56.18 | 2021-2024 | (Ck4) Mcot |
| Biosense Webster, INC. | $55.46 | 2024-2025 | Nuvision Ice Catheter |
| Janssen Scientific Affairs, LLC | $30.06 | 2023 | Xarelto |
| Scpharmaceuticals INC. | $26.84 | 2025 | |
| Angiodynamics, INC. | $22.48 | 2025 | Auryon Laser System 100-120 Vac |
| Cardiva Medical, INC. | $20.39 | 2022 | |
| Pfizer INC. | $14.04 | 2025 | |
| Lantheus Medical Imaging, INC. | $13.71 | 2020 | |
| Genzyme Corporation | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tuncay Taskesen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.